產(chǎn)品名稱 |
Human herpesvirus 5 |
商品貨號 |
B231930 |
Classification |
Herpesviridae, Cytomegalovirus |
Deposited As |
Cytomegalovirus |
Agent |
Human herpesvirus 5 |
Strain |
Davis |
Common Name |
Human cytomegalovirus |
Applications |
Sexually Transmitted Disease Research |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Isolation |
Liver biopsy, 3-month-old girl with microencephaly and other symptoms resembling congenital toxoplasmosis |
Product Format |
frozen 1.0 mL per vial |
Storage Conditions |
Vapor phase of liquid nitrogen |
Images |
|
Comments |
Virus primarily cell-associated. For each passage, perform freeze-thaws to facilitate viral release. A long (10-11 day) incubation is required for initial passage of frozen stocks. Add contents of ampule to a 80-90% monolayer of cells. For preservation, add FBS to virus culture to produce a final 20% FBS concentration. |
Effect on Host |
CPE, focal or generalized cytopathology with rounding, cytomegaly, and intranuclear inclusions |
Recommended Host |
MRC-5 cells (ATCC® CCL-171™) |
Growth Conditions |
Temperature: 37°C
Recommendations for Infection: For best results, infection should be performed on an 80-90% confluent, 18-48 hour old cellular monolayer. Prepare dilution of virus in minimum amount of volume (e.g. 1 mL per 25 cm2), optimized for propagation (e.g. MOI 0.01-0.1 recommended). Wash monolayer two times with PBS or serum free medium prior to inoculation. Adsorb virus dilution for 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 4-10 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
Name of Depositor |
T Weller |
Special Collection |
NCRR Contract |
Source |
Liver biopsy, 3-month-old girl with microencephaly, and other symptoms resembling congenital toxoplasmosis |
References |
Weller TH, et al. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc. Soc. Exp. Biol. Med. 94: 4-12, 1957. PubMed: 13400856
Weller TH, et al. Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology 12: 130-132, 1960. PubMed: 13843861
|
Cross References |
Nucleotide (GenBank) :
JX512198.1
Human herpesvirus 5 strain Davis, complete genome
|